Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

INCY

Incyte (INCY)

Incyte Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:INCY
DateTimeSourceHeadlineSymbolCompany
11/18/20108:00AMBusiness WireIncyte to Present at the 22nd Annual Piper Jaffray Health Care ConferenceNASDAQ:INCYIncyte Corporation
11/10/20105:45PMBusiness WireIncyte’s Selective Oral JAK1 & JAK2 Inhibitor Demonstrates Positive Phase IIa Results in Patients with Active Rheumatoid Ar...NASDAQ:INCYIncyte Corporation
11/10/201011:57AMBusiness WireIncyte to Host Webcast at 2010 ACR/ARHP Annual Scientific MeetingNASDAQ:INCYIncyte Corporation
11/10/20108:00AMBusiness WireIncyte to Host Webcast at 2010 ACR/ARHP Annual Scientific MeetingNASDAQ:INCYIncyte Corporation
11/09/20104:12PMEdgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:INCYIncyte Corporation
11/09/20107:21AMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:INCYIncyte Corporation
11/09/20107:00AMBusiness WireIncyte Reports Third Quarter 2010 Financial Results and Provides Update on Drug Discovery and Development ProgramsNASDAQ:INCYIncyte Corporation
11/02/20105:10PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:INCYIncyte Corporation
11/02/20107:30AMBusiness WireIncyte Achieves $50 Million in Milestones for Initiation of a Joint Global Phase III Clinical Trial of Novel JAK1 & JAK2 Inhi...NASDAQ:INCYIncyte Corporation
10/26/20104:54PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
10/26/20104:15PMBusiness WireIncyte to Report Third Quarter 2010 Financial Results and Provide Update on Drug Discovery & Development Programs on November 9NASDAQ:INCYIncyte Corporation
10/21/20104:15PMBusiness WireIncyte to Present at the Oppenheimer 21st Annual Healthcare ConferenceNASDAQ:INCYIncyte Corporation
10/20/20107:30AMBusiness WireIncyte Achieves $19 Million Milestone as Novel JAK1 & JAK2 Inhibitor Advances into Phase IIb Development for Rheumatoid Arthr...NASDAQ:INCYIncyte Corporation
09/29/20105:28AMDow Jones NewsAstra Launches Late-Stage Rheumatoid Arthritis Pill TrialsNASDAQ:INCYIncyte Corporation
09/23/20105:49PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
09/23/20105:48PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
09/23/20105:46PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
09/23/20105:43PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
09/23/20105:39PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
09/15/20105:00PMBusiness WirePhase I/II Data Published in New England Journal of Medicine Demonstrate that Incyte JAK Inhibitor, INCB18424, Provides Marke...NASDAQ:INCYIncyte Corporation
09/15/201011:36AMEdgar (US Regulatory)Confidential Treatment Order (CT ORDER)NASDAQ:INCYIncyte Corporation
09/14/20104:20PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:INCYIncyte Corporation
09/13/20107:00AMBusiness WireIncyte Reaches Agreement with the FDA on a Special Protocol Assessment for the Phase III Clinical Trial of INCB18424 in Polyc...NASDAQ:INCYIncyte Corporation
09/02/20104:15PMBusiness WireIncyte to Present at Upcoming Investor ConferencesNASDAQ:INCYIncyte Corporation
08/19/20109:55AMMarketwiredOpinions on Gilead Sciences and Incyte - Biotech Plays Losing a Little of Their AttractionNASDAQ:INCYIncyte Corporation
08/11/20105:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
08/11/20105:25PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
08/11/20105:23PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
08/11/20105:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
08/11/20105:19PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
 Showing the most relevant articles for your search:NASDAQ:INCY